By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Food and Drug Administration (FDA) 

5600 Fishers Lane

Rockville  Maryland  20857  U.S.A.
Phone: 888-463-6332 or 1-888-INFO-FDA (1-888-463-6332) Fax:

FDA Overview:

The Food and Drug Administration is one of the nation's oldest and most respected consumer protection agencies. This presentation will tell you about FDA's responsibilities, the tools we use to fulfill those responsibilities, and our priorities for improving the way we serve the public.

•Stated most simply, FDA's mission is:
- to promote and protect the public health by helping safe and effective products reach the market in a timely way,
- To monitor products for continued safety after they are in use, and
- To help the public get the accurate, science-based information needed to improve health.

FDA's Mission Statement

The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.

Key Statistics

Ownership: Private

Web Site: FDA


Company News
Shire (SHPG)'s CINRYZE Receives FDA Fast Track Designation 10/13/2015 6:23:57 AM
Collegium (COLL) Falls in Aftermarket Trading After FDA Delays Ruling on Opiod Painkiller 10/12/2015 3:31:12 PM
Bristol-Myers Squibb (BMY)’s Opdivo (Nivolumab) Receives Expanded FDA Approval In Previously-Treated Metastatic Non-Small Cell Lung Cancer (NSCLC), Offering Improved Survival To More Patients 10/12/2015 11:11:43 AM
Dako (A), An Agilent (A) Company, Announces FDA Approval Of New Test For Lung Cancer Patients 10/12/2015 10:59:44 AM
Global Blood Therapeutics (GBT) Announces GBT440 Receives FDA Fast Track Designation For Sickle Cell Disease 10/12/2015 10:16:17 AM
Endologix Announces FDA Approval Of AFX2 Bifurcated Endograft System 10/12/2015 7:23:52 AM
Naia Limited Successfully Completes Pre-IND Meeting With U.S. FDA For NB1001, Long-Acting GLP-1 (XTEN-GLP-1) Receptor Agonist For Treatment Of Short Bowel Syndrome 10/12/2015 6:45:34 AM
NuVasive (NUVA) Wins First Ever FDA 510(k) Clearance of Cervical Corpectomy Cage 10/12/2015 6:26:58 AM
Biodel (BIOD) Announces Removal of Partial FDA Clinical Hold on Phase IIb Study 3-250 10/12/2015 6:18:08 AM
FDA Confirms Luye Pharma’s 505(b)(2) NDA Submission 10/9/2015 9:53:49 AM